Endo Investors

Eric Edidin, the founder, leads investment decisions. He draws on institutional investment experience from York Capital Management, Morgan Stanley Capital Partners, and Blackstone Group. He also oversees Three B Holdings, a private family investment company, and chairs BH3 Management, a real estate firm.

The firm leverages Edidin's long-standing networks across institutional asset management and his personal proximity to the diabetes ecosystem. His daughter's diagnosis created direct connections to clinicians, researchers, and patient-advocacy groups. Edidin's former board role with JDRF of Los Angeles also provides access to early-stage innovations in diabetes care.

Endo operates as a private equity asset manager, though it sits within a broader family-investment architecture. Edidin concurrently serves as president of Three B Holdings, a private family investment company, and executive chairman of BH3 Management. The firm does not disclose whether it manages external limited-partner capital alongside Edidin's own.

Endo focuses on early-stage, venture, and growth-stage life-sciences companies, with occasional restructuring situations. The firm has backed preclinical biotechnology companies such as Illuminare Biotechnologies and clinical-stage firms like ILiAD Biotechnologies, alongside later-stage digital health platforms like Cecelia Health.

Endo does not publicly publish an exclusion list, but its entire known portfolio concentrates on life sciences, specifically diabetes technology, metabolic disease, infectious disease, and chronic-condition management. No disclosed investments sit outside healthcare.

Eric Edidin is the connective figure. He founded Endo Investors in 2013, serves as president of Three B Holdings, and acts as executive chairman of BH3 Management. The firms share a principal but maintain separate mandates: direct life-sciences venture, family-office investing, and real estate respectively.

The firm itself lists no philanthropic arm, but Edidin has a history of board service with JDRF of Los Angeles, the Jewish Communal Fund of NY, and the Jewish Federation of Los Angeles. He currently serves on the board of ELNET US and chairs ELNET–Central and Eastern Europe. These roles are separate from Endo's investment activities.